A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.
Eur Respir J
; 58(3)2021 09.
Article
in En
| MEDLINE
| ID: mdl-34385263
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Disease, Chronic Obstructive
/
Eosinophils
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Eur Respir J
Year:
2021
Document type:
Article
Affiliation country:
Reino Unido